Partial mixing and the formation of 13C pockets in AGB stars: effects on the s-process elements

The production of the elements heavier than iron via slow neutron captures (the s process) is a main feature of the contribution of asymptotic giant branch (AGB) stars of low mass (< 5 Msun) to the chemistry of the cosmos. However, our understanding of the main neutron source, the 13C(alpha,n)16O reaction, is still incomplete. It is commonly assumed that in AGB stars mixing beyond convective borders drives the formation of 13C pockets. However, there is no agreement on the nature of such mixing and free parameters are present. By means of a parametric model we investigate the impact of different mixing functions on the final s-process abundances in low-mass AGB models. Typically, changing the shape of the mixing function or the mass extent of the region affected by the mixing produce the same results. Variations in the relative abundance distribution of the three s-process peaks (Sr, Ba, and Pb) are generally within +/-0.2 dex, similar to the observational error bars. We conclude that other stellar uncertainties - the effect of rotation and of overshoot into the C-O core - play a more important role than the details of the mixing function. The exception is at low metallicity, where the Pb abundance is significantly affected. In relation to the composition observed in stardust SiC grains from AGB stars, the models are relatively close to the data only when assuming the most extreme variation in the mixing profile.Comment: 17 pages, 8 figures, 6 tables, accepted for publications on Monthly Notices of the Royal Astronomical Societ

Aging and PBX 9502

Components made from PBX 9502, an insensitive high explosive formulated with triaminotrinitrobenzene (TATB) and Kel-F 800 binder, have been in service for nearly two decades. Since that time, samples have been destructively evaluated to determine if potential changes that might affect safety, reliability, or performance have occurred in the high explosive with time. Data from routine, historical testing is reported elsewhere. This paper focuses on specific tests conducted to evaluate the effects of natural aging on handling sensitivity (through the small-scale tests of Human Electrostatic Discharge, friction, and Drop Weight Impact), compressive strength, and thermal ignition. Also reported are the effects of a radiation environment on TATB. Small-scale sensitivity tests show no differences between aged and unaged material. Observed differences in compressive strength behavior are attributed to conditions of original material rather than aging effects. Thermal ignition by flame and laser methods showed no changes between aged and unaged material. Extreme levels of radiation are shown to have only minimal effects in explosive response tests. PBX 9502 is concluded, once again, to be a very stable material, aging gracefully

Pediatric DXA: clinical applications

Normal bone mineral accrual requires adequate dietary intake of calcium, vitamin D and other nutrients; hepatic and renal activation of vitamin D; normal hormone levels (thyroid, parathyroid, reproductive and growth hormones); and neuromuscular functioning with sufficient stress upon the skeleton to induce bone deposition. The presence of genetic or acquired diseases and the therapies that are used to treat them can also impact bone health. Since the introduction of clinical DXA in pediatrics in the early 1990s, there has been considerable investigation into the causes of low bone mineral density (BMD) in children. Pediatricians have also become aware of the role adequate bone mass accrual in childhood has in preventing osteoporotic fractures in late adulthood. Additionally, the availability of medications to improve BMD has increased with the development of bisphosphonates. These factors have led to the increased utilization of DXA in pediatrics. This review summarizes much of the previous research regarding BMD in children and is meant to assist radiologists and clinicians with DXA utilization and interpretation

Analyzing a fake news authorship network

This project synthesizes a set of 246 fake news websites previously identified in three earlier research projects. From this dataset, we extract a set of all authors who have written for these sites in 2016. This authorcentric dataset is itself a contribution that will allow future analysis of the fake news ecosystem. Based on the data we collected, we construct a network of fake news sites, linking them if they shared a common author. Our analysis shows a tight cluster of author-sharing sites, with a small core set of sites sharing dozens of authors

Effectiveness of a cough management algorithm at the transitional phase from acute to chronic cough in Australian children aged <15 years: Protocol for a randomised controlled trial

Introduction Acute respiratory infections (ARIs) are leading causes of hospitalisation in Australian children and, if recurrent, are associated with increased risk of chronic pulmonary disorders later in life. Chronic ( > 4 weeks) cough in children following ARI is associated with decreased quality-of-life scores and increased health and societal economic costs. We will determine whether a validated evidence-based cough algorithm, initiated when chronic cough is first diagnosed after presentation with ARI, improves clinical outcomes in children compared with usual care. Methods and analysis A multicentre, parallel group, open-label, randomised controlled trial, nested within a prospective cohort study in Southeast Queensland, Australia, is underway. 750 children aged < 15 years will be enrolled and followed weekly for 8 weeks after presenting with an ARI with cough. 214 children from this cohort with persistent cough at day 28 will be randomised to either early initiation of a cough management algorithm or usual care (107 per group). Randomisation is stratified by reason for presentation, site and total cough duration at day 28 ( < 6 and ≥6 weeks). Demographic details, risk factors, clinical histories, examination findings, cost-of-illness data, an anterior nasal swab and parent and child exhaled carbon monoxide levels (when age appropriate) are collected at enrolment. Weekly contacts will collect cough status and cost-of-illness data. Additional nasal swabs are collected at days 28 and 56. The primary outcome is time-to-cough resolution. Secondary outcomes include direct and indirect costs of illness and the predictors of chronic cough postpresentation

Outcomes of protracted bacterial bronchitis in children: a 5-year prospective cohort study

Background and objective Long‐term data on children with PBB has been identified as a research priority. We describe the 5‐year outcomes for children with PBB to ascertain the presence of chronic respiratory disease (bronchiectasis, recurrent PBB and asthma) and identify the risk factors for these. Methods Prospective cohort study was undertaken at the Queensland Children's Hospital, Brisbane, Australia, of 166 children with PBB and 28 controls (undergoing bronchoscopy for symptoms other than chronic wet cough). Monitoring was by monthly contact via research staff. Clinical review, spirometry and CT chest were performed as clinically indicated. Results A total of 194 children were included in the analysis. Median duration of follow‐up was 59 months (IQR: 50–71 months) post‐index PBB episode, 67.5% had ongoing symptoms and 9.6% had bronchiectasis. Significant predictors of bronchiectasis were recurrent PBB in year 1 of follow‐up (ORadj = 9.6, 95% CI: 1.8–50.1) and the presence of Haemophilus influenzae in the BAL (ORadj = 5.1, 95% CI: 1.4–19.1). Clinician‐diagnosed asthma at final follow‐up was present in 27.1% of children with PBB. A significant BDR (FEV1 improvement >12%) was obtained in 63.5% of the children who underwent reversibility testing. Positive allergen‐specific IgE (ORadj = 14.8, 95% CI: 2.2–100.8) at baseline and bronchomalacia (ORadj = 5.9, 95% CI: 1.2–29.7) were significant predictors of asthma diagnosis. Spirometry parameters were in the normal range. Conclusion As a significant proportion of children with PBB have ongoing symptoms at 5 years, and outcomes include bronchiectasis and asthma, they should be carefully followed up clinically. Defining biomarkers, endotypes and mechanistic studies elucidating the different outcomes are now required